This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Tracking 8 Stocks that Beat EPS but Are Underperforming

Qualcomm (QCOM - Get Report) ($65.45) beat EPS estimates by 14 cents a share at $1.14 per share on Jan. 30. The stock traded up to $67.44 on Jan. 31 then moved sideways to down since then. The stock has a hold rating with a positive weekly chart profile with the five-week MMA at $64.64. My annual value level is $64.58 with a monthly pivot at $66.12 and a quarterly risky level at $67.15.

Under Armour (UA - Get Report) ($48.70) beat EPS estimates by a penny earning 47 cents per share on Jan. 31. The stock popped to $51.94 for a failed test of the 200-day simple moving average at $51.80, then drifted lower since then to $48.48 yesterday. The stock has a hold rating and a neutral weekly chart profile with the stock below its five-week MMA at $49.30. My semiannual value level lags at $42.97 with a weekly pivot at $49.42 and semiannual risky level at $52.01.


United Parcel Service (UPS - Get Report) ($82.50) missed EPS estimates by 6 cents earning $1.32 per share on Jan. 31, but the stock proved to be resilient. The stock traded down to $79.00 on Feb. 1 then up to a new multi-year high at $83.08 on Feb. 12. UPS kept a buy rating during this volatility with an overbought weekly chart profile and the five-week MMA at $79.37. Stability was influenced by my semiannual pivot at $80.21 with a monthly value level at $75.82 and weekly risky level at $84.84.

Chevron (CVX) ($115.53) missed EPS estimates by 5 cents earning $2.98 per share on Feb. 1. The stock drifted sideways since then while maintaining a buy rating with a positive weekly chart profile, and the five-week MMA at $113.59. My semiannual value level is $111.22 with a weekly pivot at $118.32, a quarterly risky level at $120.94 and annual risky levels at $122.26 and $123.08.

Merck (MRK) ($41.15) beat EPS estimates by 2 cents earning 83 cents per share on Feb. 1. Guidance was light and the stock declined from $43.25 on Jan. 31 to $40.83 on Feb. 4 then sideways since then. The stock has maintained a buy rating with a negative weekly chart profile and the five-week MMA at $42.23. My quarterly value level is $40.81 with my semiannual risky level at $43.41.

2 of 4

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG
BA $148.40 0.00%
QCOM $68.24 0.00%
UPS $98.10 0.00%
UA $82.56 0.00%
XOM $86.97 0.00%

Markets

DOW 18,080.14 +21.45 0.12%
S&P 500 2,117.69 +4.76 0.23%
NASDAQ 5,092.0850 +36.0220 0.71%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs